Latest papers

Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray.

Effects of breast-conserving therapy on lactation after pregnancy.

Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray.

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.

Antioxidative response for nitric oxide production in breast carcinoma.

Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

Correlation between VEGF expression and angiogenesis in breast carcinoma.

Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.

Breast cancer in young women ( or = 35 years): Genomic aberrations detected by comparative genomic hybridization.

Expression of TRAG-3 in breast cancer.

Tissue and serum MUC1 mucin detection in breast cancer patients.

Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer.

Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients.

Risk factors for colorectal cancer following breast cancer.

Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.

Missed breast carcinoma: pitfalls and pearls.

Molecular genetics and histopathologic features of adult distal nephron tumors.

Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors.